In addition, the FDA found that approving the GE salmon would not have a significant environmental impact
U.S. Food and Drug Administration
Action expected to reduce coronary heart disease and prevent thousands of fatal heart attacks every year.
If you’re allergic to natural rubber latex, the U.S. Food and Drug Administration has good news for you: in the future, you are less likely to be misinformed about the absence of this allergen in such products as medical devices. To avoid false assurances about this hazard to your health, FDA is recommending to manufacturers to stop using the labels “latex-free” or “does not contain latex.”
The U.S. Food and Drug Administration finalized two rules on Nov. 25 requiring that calorie information be listed on menus and menu boards in chain restaurants, similar retail food establishments and vending machines with 20 or more locations to provide consumers with more nutritional information about the foods they eat outside of the home. The rules are required by the 2010 Patient Protection and Affordable Care Act.
Recently, you may have heard some concerns suggesting the FDA has taken steps to end the long-standing practice in the cheesemaking industry of using wooden boards to age cheese. To be clear, we have not and are not prohibiting or banning the long-standing practice of using wood shelving in artisanal cheese. Nor does the FDA Food Safety Modernization Act (FSMA) require any such action. Reports to the contrary are not accurate.
Some important news for those involved in the food science world.
Exploiting the public's rising concern about concussions, some companies are offering possibly dangerous products that claim to cure traumatic brain injuries
Reducing trans fat intake could prevent thousands of heart attacks and deaths.
The U.S. Food and Drug Administration today announced a public-private partnership to help identify counterfeit or substandard anti-malarial medicines, including falsified products, with the deployment of the FDA-developed Counterfeit Detection Device, called CD-3.
The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.